• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE, ABBOTT, SENSOR SENSOR.; SENSOR, GLUCOSE, INVASIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE, ABBOTT, SENSOR SENSOR.; SENSOR, GLUCOSE, INVASIVE Back to Search Results
Model Number 71525-01
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem Pain (1994)
Event Date 12/29/2018
Event Type  Injury  
Event Description
Freestyle libre glucose monitoring system: the monitor box does not clearly distinguish between a 10 day or a 14 day reader.The pharmacy attached a 14 day reader label/prescription label to the box which does not clearly indicate whether it is a 10 or 14 day reader.Subsequently the pharmacy issued a 14 day sensor, however the readers do not read ten-day freestyle libre glucose monitoring system: the monitor box that comes with the monitor and it does not clearly distinguish between a 10 day and a 14 day reader.The pharmacy attached a 14 day reader label/prescription label to the box which does not clearly indicate whether it is a 10 or 14 gauge reader.Subsequently the pharmacy issued a 14 day sensor; however the monitors are not compatible inversely with 10 to 14 day readers.The reader must be compatible with the same sensor.A ten day reader must have a 10 day sensor.Even though the pharmacy put the incorrect label on the box, if the consumer does not know which is a ten day box and which is a 14 day box they cannot check the accuracy of the pharmacy's work.Having an elderly patient/family member who is very stressed from having to stick their fingers and more painful as they have aged.Combine this with other medical issues and it creates a very unsettled patient and household.If labeling is not clearly understandable how can the patient, family, provider, pharmacy be expected to verify that the box/packaging matches the necessary prescription? dose or amount: 1 topical skin with device attached, route: applied to a surface, usually the skin.Dates of use: (b)(6) 2018.Diagnosis or reason for use: diabetes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE, ABBOTT, SENSOR SENSOR.
Type of Device
SENSOR, GLUCOSE, INVASIVE
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
MDR Report Key8212758
MDR Text Key132146395
Report NumberMW5082778
Device Sequence Number1
Product Code MDS
UDI-Device Identifier00357599000219
UDI-Public00357599000219
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 12/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/02/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/31/2018
Device Model Number71525-01
Device Lot Number01Y695D
Was Device Available for Evaluation? Yes
Was Device Evaluated by Manufacturer? No Information
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient Weight59
-
-